172 filings
Page 6 of 9
6-K
lxnkrbz4e
29 Apr 20
Aptorum Group Limited Reports 2019 Fiscal Year End Financial Results and Provides Business Update
8:01am
6-K
32l6q
30 Mar 20
Report of Foreign Private Issuer
8:00am
424B5
8tz3 bgf0f2p
27 Feb 20
Prospectus supplement for primary offering
5:33pm
6-K
c9w 39va4m1w4fozcic2
26 Feb 20
Alliance Global Partners
1:20pm
6-K
gn4wl 8u06lis
24 Feb 20
Aptorum Group Commences Commercialization of Dioscorea Opposita Bioactive Nutraceutical Tablets and Signed Sales Distribution Agreement in Hong Kong
6:02am
6-K
9fx8jtsb
10 Feb 20
Aptorum Group Announces Significant Progress of Repurposed Drug Candidate, SACT-1 for Neuroblastoma Targeting IND Submission in H2 2020
8:01am
EFFECT
sm3ujqg
16 Jan 20
Notice of effectiveness
12:15am
UPLOAD
402u889sz
14 Jan 20
Letter from SEC
12:00am
CORRESP
9yeapq
14 Jan 20
Correspondence with SEC
12:00am
6-K
s4qw1 4ef
13 Jan 20
Current report (foreign)
6:01am
F-3
pyih6c bdvohx
6 Jan 20
Shelf registration (foreign)
4:19pm
RW
rcorjut
26 Dec 19
Registration withdrawal request
10:46am
F-3
ep40i16cp
18 Dec 19
Shelf registration (foreign)
10:19am
424B3
96oi4cm
26 Nov 19
Prospectus supplement
11:11am
EFFECT
86ldg
20 Nov 19
Notice of effectiveness
12:15am
6-K
qdkrc
15 Nov 19
Aptorum Group Limited Announces Results of 2019 Annual General Meeting
9:30am
POS AM
uwzzcqromajo1v4mu3
12 Nov 19
Prospectus update (post-effective amendment)
4:13pm
424B3
qrnyghxou6dk qq2ai
31 Oct 19
Prospectus supplement
11:38am
6-K
t8tc32 radb0l
25 Oct 19
Report of Foreign Private Issuer
6:04am
EFFECT
5ovahq6
25 Oct 19
Notice of effectiveness
12:15am